Cilastatin EP Impurity B - Request Quote
Cilastatin EP Impurity B
| SZ CAT No: | SZ-C073004 |
| CAS No | NA |
| Mol.F. | C21H34N2O6S |
| Mol.Wt. | 442.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cilastatin EP Impurity B is chemically (Z)-7-[[(2R)-2-carboxy-2-[[(1RS)-1-methyl-3-oxobutyl]amino]ethyl]sulfanyl]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]hept-2-enoic acid (as per EP). Cilastatin EP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Cilastatin EP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cilastatin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cilastatin EP Impurity B
Purchase Cilastatin EP Impurity B
Cilastatin EP Impurity B suppliers
Cilastatin EP Impurity B manufacturers
Cilastatin EP Impurity B price
Order Cilastatin EP Impurity B
Enquire Cilastatin EP Impurity B
Cilastatin EP Impurity B cost
Cilastatin EP Impurity B Supplier
Cilastatin EP Impurity B Distributor
Cilastatin EP Impurity B for Method Validation
Cilastatin Reference Standard
Cilastatin EP Impurity B for ANDA Filing
Cilastatin EP Impurity B for Forced Degradation Studies
Cilastatin EP Impurity B Identification Standards
Cilastatin EP Impurity B for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.